No Data
Quoin Pharmaceuticals Launches 'NETHERTON NOW' Campaign to Raise Awareness of Netherton Syndrome, a Rare Genetic Disease With No Approved Treatment or Cure
Insider Buyers At Quoin Pharmaceuticals Likely Disappointed With 13% Slide
12 Health Care Stocks Moving In Friday's Pre-Market Session
Quoin Pharmaceuticals: Buy Rating Affirmed Amidst Potential First-Mover Advantage in Netherton Syndrome Treatment
Skinvisible Advances With Quoin Pharmaceuticals' FDA Clearance
Quoin Pharmaceuticals Announces Further Clinical Evidence on QRX003 Efficacy
